Health Care: Drugs

Eli Lilly and Co (LLY: NYSE)

$82.35 -0.84 | -1.01%
08/31/15 - 04:03 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 19.62B 23.11B 22.60B 24.29B
Cost of Sales 3.55B 3.46B 3.33B 3.69B
Gross Operating Profit 16.06B 19.65B 19.27B 20.59B
Selling, General, and Administrative Expenses 6.62B 7.13B 7.51B 7.88B
Research & Development 4.73B 5.53B 5.28B 5.02B
Operating Income before D & A (EBITDA) 4.71B 6.99B 6.48B 7.69B
Depreciation & Amortization 1.38B 1.45B 1.46B 1.37B
Interest Income 121.00M 119.70M 105.00M 79.90M
Other Income - Net -300.60M 559.30M 0.00 -72.90M
Special Income / Charges 0.00 -234.80M 465.70M -1.18B
Total Income Before Interest Expenses (EBIT) 3.15B 6.05B 5.59B 5.54B
Interest Expense 148.80M 160.10M 177.80M 186.00M
Pre-Tax Income 3.00B 5.89B 5.41B 5.35B
Income Taxes 609.80M 1.20B 1.32B 1.00B
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 2.39B 4.68B 4.09B 4.35B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.39B 4.68B 4.09B 4.35B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.39B 4.68B 4.09B 4.35B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.39B 4.86B 3.62B 5.14B
Preferred Dividends
Net Income Available To Common 2.39B 4.68B 4.09B 4.35B
Basic EPS from Continuing Ops. 2.23 4.33 3.67 3.93
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.23 4.33 3.67 3.93
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 -0.03
Basic EPS, Total 2.23 4.33 3.67 3.90
Basic Normalized Net Income/Share 2.23 4.50 3.25 4.64
EPS fr Continuing Ops. 2.23 4.32 3.66 3.90
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.23 4.32 3.66 3.90
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.23 4.32 3.66 3.90
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.23 4.48 3.24 4.61
Dividends Paid per Share 1.96 1.96 1.96 1.96

Portfolios with LLY

Latest LLY Headlines from TheStreet

More Financial News for LLY

Press Releases for LLY

See All Press Releases

Partner Headlines for LLY

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter